ESTRO35 Programme Book

> Neoadjuvant chemoradiation in Locally Advanced NSCLC: impact of histology and drugs on results. B. Floreno (Italy), R.M. D’Angelillo, M. Fiore, C. Greco, E. Molfese, C.G. Rinaldi, L.E. Trodella, A. Iurato, L. Trodella, S. Ramella > Outcome after stereotactic radiotherapy for brain metastasis of lung cancer: a retrospective study N. Grellier Adedjouma (France), A. Levy, A. Suissa, F. Belkhir, P. Xu, F. Martinetti, D. Planchard, B. Besse, C. Le Péchoux > Stereotactic Body Radiation Therapy (SBRT) for recurrent lung cancer following prior radiation J. Wurzer (USA), M. Mackowsky > Oligometastatic NSCLC: long-term results show efficiency of radical approaches in selected patients A. Bunea (Germany), D. Schiebahn, D. Schanne, T. Schimek-Jasch, E. Gkika, S. Wiesemann, J. Rawluk, C. Waller, A.L. Grosu, U. Nestle > Local control and toxicity for centrally located NSCLC: SABR in no fly zone C. Menichelli (Italy), G. Pastore, A. Fanelli, S. Grespi, P. Ferrazza, A. Chella, I. Petrini, F. Casamassima > Updated outcomes for patients treated with SABR for lung cancer at the Leeds Cancer Centre P. Murray (UK), K. Spencer, P. Dickinson, M. Snee, P. Jain, K. Clarke, K. Franks > SABR and FDG-PET in lung cancer: a SUV cut-off value before treatment to predict local control. S. Vagge (Italy), M. Marcenaro, G. Timon, G. Siffredi, R. Corvò

EP-1249

ELECTRONIC POSTERS

EP-1250

EP-1251

EP-1252

EP-1253

EP-1254

EP-1255

Electronic Poster CLINICAL TRACK: UPPER GI (OESOPHAGUS, STOMACH, PANCREAS, LIVER)

> Stereotactic body radiation therapy for liver metastases using RapidArc technique E. Del Cerro (Spain), A.A. Diaz Gavela, F. Couñago Lorenzo, F. Marcos Jimenez, E. Pardo Perez, Y. Molina Lopez

EP-1256

INTERDISCIPLINARY RADIOBIOLOGY

CLINICAL BRACHYTHERAPY PHYSICS

RTT

YOUNG

POSTERS AND ELECTRONIC POSTERS | PROGRAMME AND EXHIBITION GUIDE

236